Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer

被引:163
|
作者
Liu, HH
Wang, XC
Dong, L
Wu, QW
Liao, ZX
Stevens, CW
Guerrero, TM
Komaki, R
Cox, JD
Mohan, R
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Virginia Commonwealth Univ, Dept Radiat Oncol, Richmond, VA USA
关键词
intensity-modulated radiotherapy; non-small-cell lung cancer; integral dose; low-dose volumes; lung toxicity;
D O I
10.1016/j.ijrobp.2003.09.085
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To investigate the possibility of using intensity-modulated radiotherapy (IMRT) to reduce the irradiated volumes of the normal lung and other critical structures in the treatment of non-small-cell lung cancer (NSCLC) and to investigate the effect of IMRT on the potential of spreading low doses to large volumes of normal tissues in such treatment. Methods and Materials: A retrospective treatment planning study was performed to compare IMRT and conventional three-dimensional conformal radiation therapy (3D-CRT) for 10 NSCLC patients (Stage I-IIIB). In the IMRT plans, three to nine coplanar beams were designed to treat 95% of the planning target volume with 63 Gy and to minimize the volumes of the normal lung, esophagus, heart, and spinal cord irradiated above their tolerance doses. The two types of plans were compared with respect to the planning target volume coverage, dose-volume histograms, and other dosimetric indexes of the normal structures. Results: Comparing the nine-beam IMRT plan with the 3D-CRT plan, the percentage of lung volume that received >20 Gy and the mean lung dose were reduced for all cases, with a median reduction of 8% and 2 Gy, respectively. An additional reduction of the >5-Gy volume and >10-Gy volume for the lung and thoracic tissue was more difficult with IMRT, although still possible using fewer beams in IMRT. The integral dose to the entire thorax was equivalent and even reduced for 8 of 10 cases using IMRT. Conclusion: It is possible to reduce the volumes of low doses (such as the >10-Gy volume and >20-Gy volume) for thoracic normal tissues using IMRT. The increased integral dose and low-dose volumes can be avoided for IMRT if such concerns are addressed carefully in the inverse planning process and with optimization of the IMRT beam configuration. (C) 2004 Elsevier Inc.
引用
收藏
页码:1268 / 1279
页数:12
相关论文
共 50 条
  • [21] Effectiveness of Intensity-modulated Radiotherapy for Lung Cancer
    Hsia, T. C.
    Tu, C. Y.
    Chen, H. J.
    Chien, C. R.
    CLINICAL ONCOLOGY, 2013, 25 (07) : 447 - 448
  • [22] Learning curve of lung dose optimization in intensity-modulated radiotherapy for locally advanced non-small cell lung cancer
    Igari, Mitsunobu
    Abe, Takanori
    Iino, Misaki
    Saito, Satoshi
    Aoshika, Tomomi
    Ryuno, Yasuhiro
    Ohta, Tomohiro
    Hirai, Ryuta
    Kumazaki, Yu
    Noda, Shin-ei
    Kato, Shingo
    THORACIC CANCER, 2023, 14 (26) : 2642 - 2647
  • [23] Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer
    Choi, YM
    Kim, JK
    Lee, HS
    Hur, WJ
    Chai, GY
    Kang, KM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (03): : 683 - 689
  • [24] Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer
    Hideyuki Harada
    Shota Omori
    Keita Mori
    Masahiro Konno
    Haruyasu Murakami
    Toshiyuki Imagumbai
    Haruyuki Fukuda
    Kiyoshi Nakamatsu
    Tomoki Kimura
    Hiroaki Tanabe
    Hideki Fujita
    Hitoshi Tatebe
    Kazunori Fujitaka
    Yasumasa Nishimura
    International Journal of Clinical Oncology, 2022, 27 : 1025 - 1033
  • [25] Multi-institutional feasibility study of intensity-modulated radiotherapy with chemotherapy for locally advanced non-small cell lung cancer
    Harada, Hideyuki
    Omori, Shota
    Mori, Keita
    Konno, Masahiro
    Murakami, Haruyasu
    Imagumbai, Toshiyuki
    Fukuda, Haruyuki
    Nakamatsu, Kiyoshi
    Kimura, Tomoki
    Tanabe, Hiroaki
    Fujita, Hideki
    Tatebe, Hitoshi
    Fujitaka, Kazunori
    Nishimura, Yasumasa
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (06) : 1025 - 1033
  • [26] Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study
    Ji, K.
    Zhao, L. J.
    Liu, W. S.
    Liu, Z. Y.
    Yuan, Z. Y.
    Pang, Q. S.
    Wang, J.
    Wang, P.
    BRITISH JOURNAL OF RADIOLOGY, 2014, 87 (1035):
  • [27] Palliative thoracic radiotherapy for non-small-cell lung cancer - A systematic review
    Toy, E
    Macbeth, F
    Coles, B
    Melville, A
    Eastwood, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (02): : 112 - 120
  • [28] Hypofractionated Intensity-Modulated Radiation Therapy for Stage III Non-Small-Cell Lung Cancer: A Retrospective Study
    Zhu, X.
    Kong, C.
    He, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E721 - E721
  • [29] Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non-small-cell lung cancer
    Itonaga, Tomohiro
    Mikami, Ryuji
    Nakayama, Hidetsugu
    Saito, Tatsuhiko
    Shiraishi, Sachika
    Okubo, Mitsuru
    Sugahara, Shinji
    Ikeda, Norihiko
    Tokuuye, Koichi
    JOURNAL OF RADIATION RESEARCH, 2019, 60 (03) : 387 - 393
  • [30] Esophagitis Following Intensity-Modulated Radiotherapy for Lung Cancer
    Miller, N. G.
    Weiss, E.
    Yuan, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (01): : E5 - E6